Literature DB >> 15774832

Meconium inhibits phagocytosis and stimulates respiratory burst in alveolar macrophages.

Sylvia Craig1, Alfonso Lopez, David Hoskin, Fred Markham.   

Abstract

The meconium aspiration syndrome is an important cause of respiratory distress in newborn infants. Alveolar macrophages (AMs) provide a first line of defense in the lower respiratory tract against inhaled pathogens and particles such as meconium. In this study, we examined the effect of meconium on two primary macrophage functions: phagocytosis and respiratory burst. Short-term exposure of rat NR8383 AMs to sterile meconium from human or equine neonates (1.2-24 mg/mL) produced a dose-dependent decrease in phagocytosis of fluorescent latex beads. This effect was not due to decreased cell viability or to an elevation of intracellular cAMP. The effect of short-term exposure to meconium on the respiratory burst response in AMs was quantified using flow cytometry to measure oxidation of dichlorofluorescin diacetate. A robust respiratory burst was triggered when AMs were exposed to 12 or 24 mg/mL meconium. This effect was attenuated but not eliminated by filtration of the meconium. However, subsequent to meconium exposure, AMs had a reduced respiratory burst in response to stimulation with phorbol myristate acetate. In addition, AMs that were exposed to meconium for an extended period (24 h) showed DNA fragmentation indicative of apoptosis. Meconium therefore may interfere with AM function by inducing oxidative stress and apoptosis. Tissue injury from release of reactive oxygen species by AMs may be important in the pathophysiology of the meconium aspiration syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774832     DOI: 10.1203/01.PDR.0000157724.02332.8B

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  A study of oxidative stress in neonates delivered through meconium-stained amniotic fluid.

Authors:  Tapas Bandyopadhyay; B D Bhatia; H D Khanna
Journal:  Eur J Pediatr       Date:  2017-01-06       Impact factor: 3.183

2.  Role of prophylactic antibiotics in neonates born through meconium-stained amniotic fluid (MSAF)--a randomized controlled trial.

Authors:  Ankita Goel; Sushma Nangia; Arvind Saili; Akanksha Garg; Sunita Sharma; V S Randhawa
Journal:  Eur J Pediatr       Date:  2014-08-03       Impact factor: 3.183

3.  Gestational diabetes mellitus is associated with increased CD163 expression and iron storage in the placenta.

Authors:  Theresa L Barke; Jeffery A Goldstein; Alexandra C Sundermann; Arun P Reddy; Jodell E Linder; Hernan Correa; Digna R Velez-Edwards; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2018-07-09       Impact factor: 3.886

4.  Amelioration of meconium-induced acute lung injury by parecoxib in a rabbit model.

Authors:  Ai-Min Li; Li-Na Zhang; Wen-Zhi Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 5.  Glucocorticoids in the treatment of neonatal meconium aspiration syndrome.

Authors:  Daniela Mokra; Juraj Mokry
Journal:  Eur J Pediatr       Date:  2011-04-06       Impact factor: 3.183

6.  Recombinant Human Superoxide Dismutase and N-Acetylcysteine Addition to Exogenous Surfactant in the Treatment of Meconium Aspiration Syndrome.

Authors:  Jana Kopincova; Maros Kolomaznik; Pavol Mikolka; Petra Kosutova; Juliana Topercerova; Katarina Matasova; Andrea Calkovska; Daniela Mokra
Journal:  Molecules       Date:  2019-03-05       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.